Skip to main content
PMC home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;23(9):637–644. doi: 10.1002/clc.4960230903

Pulmonary embolus after coronary artery bypass surgery: A review of the literature

Nicolas W Shammas 1,✉
PMCID: PMC6654922  PMID: 11016012

Abstract

Pulmonary embolus (PE) after cardiac bypass surgery is an uncommon complication but carries with it high morbidity and mortality. The incidence of deep vein thrombosis (DVT) and PE after cardiac bypass varies depending on postoperative thromboprophylaxis, the presence of indwelling central venous catheters in the lower extremities, and early ambulation. The clinical diagnosis of DVT remains difficult and challenging. Pulmonary embolus is often the first occurring clinical event. The safety and effectiveness of preventative pharmacologic agents, such as subcutaneous unfraction‐ated or fractionated heparin or oral Coumadin, remain largely unknown. Heparin‐induced thrombocytopenia, generally associated with a high incidence of DVT and PE, occurs in approximately 3.8% of patients who have undergone cardiac surgery and are placed postoperatively on high‐dose intravenous unfractionated heparin. Sequential compression devices (SCD) have not been effective in reducing the incidence of DVT in an ambulating cardiac bypass patient when added to routine elastic graded compression stockings (GCS). Very large clinical trials are necessary to prove the effectiveness of pharmacologic or mechanical preventative measures in reducing the incidence of PE after cardiac surgery above the commonly used GCS, early ambulation, and aspirin. In a nonam‐bulating, higher‐risk cardiac bypass patient with slow recovery, a more aggressive prophylaxis regimen might be necessary for optimal prevention, although further data are needed to support this hypothesis.

Keywords: pulmonary embolus, cardiac bypass, heparin, platelets, graded compression stockings

Full Text

The Full Text of this article is available as a PDF (995.5 KB).

References

  • 1. Sharma GVRK, Sasahara AA: Diagnosis and treatment of pulmonary embolism. Med Clin North Am 1979; 63: 239–250 [DOI] [PubMed] [Google Scholar]
  • 2. Paiement GD, Desautels C: Deep vein thrombosis: Prophylaxis, diagnosis, and treatment—lessons from orthopedic studies. Clin Cardiol 1990; 13: 19–22 [PubMed] [Google Scholar]
  • 3. Reis SE, Polak JF, Hirsh DR, Conn LH, Greager MA, Donovan BC, Goldhaber SZ: Frequency of deep venous thrombosis in asymptomatic patients with coronary artery bypass grafts. Am Heart J 1991; 122: 478–482 [DOI] [PubMed] [Google Scholar]
  • 4. Stulberg BN, Insall JN, Williams GW, Ghelman B: Deep‐vein thrombosis following total knee replacement. J Bone Joint Surg (Am) 1984; 66: 194–201 [PubMed] [Google Scholar]
  • 5. Josa M, Siouffi SY, Silverman AB, Barsamian EM, Khuri SF, Sharma GVRK: Pulmonary embolus after cardiac surgery. J Am Coll Cardiol 1993; 21: 990–996 [DOI] [PubMed] [Google Scholar]
  • 6. DeLaria GA, Hunter JA: Deep vein thrombosis. Implications after open heart surgery. Chest 1991; 99: 284–288 [DOI] [PubMed] [Google Scholar]
  • 7. Consensus Conference : Prevention of venous thrombosis and pulmonary embolism. J Am Med Assoc 1986; 256: 744–749 [PubMed] [Google Scholar]
  • 8. Goldhaber SZ, Hirsh DR, MacDougall RC, Polak JF, Creager MA, Cohn LH: Prevention of venous thrombosis after coronary artery bypass surgery (a randomized trial comparing two mechanical prophylaxis strategies). Am J Cardiol 1995; 76: 993–996 [DOI] [PubMed] [Google Scholar]
  • 9. Rao G, Zikria EA, Miller WH, Samadani SR, Ford WB: Incidence and prevention of pulmonary embolism after coronary artery surgery. J Vasc Surg 1975; 9: 37–45 [DOI] [PubMed] [Google Scholar]
  • 10. Wisoff BG, Hartstein ML, Aintablian A, Hamby R: Risk of coronary surgery. Two hundred consecutive patients with no hospital deaths. J Thorac Cardiovasc Surg 1975; 69: 669–673 [PubMed] [Google Scholar]
  • 11. Gillinov AM, Davis EA, Alberg AJ, Rykiel M, Gardner TJ, Cameron DE: Pulmonary embolism in the cardiac surgical patient. Ann Thorac Surg 1992; 53: 988–991 [DOI] [PubMed] [Google Scholar]
  • 12. Pouplard C, May M‐A, Iochmann S, Amiral J, Vissac A‐M, Marchand M, Gruel Y: Antibodies to platelet factor 4‐heparin after cardiopulmonary bypass in patients anticoagulated with unfrac‐tionated heparin or a low‐molecular weight heparin. Clinical implications for heparin‐induced thrombocytopenia. Circulation 1999; 99: 2530–2536 [DOI] [PubMed] [Google Scholar]
  • 13. Antiplatelet Trialists' Collaboration : Collaborative overview of randomized trials of antiplatelet therapy‐III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Br Med J 1994; 308: 235–308 [PMC free article] [PubMed] [Google Scholar]
  • 14. Bell WR, Simon TL: Current status of pulmonary thromboembolic disease: Pathophysiology, diagnosis, prevention and treatment. Am Heart J 1982; 103: 239–262 [DOI] [PubMed] [Google Scholar]
  • 15. Mabee SW, Mabee CL, Pacht ER: Normal arterial blood gas in a patient with saddle pulmonary artery embolus: Diagnosis by transesophageal echocardiography. J Nat Med Assoc 1995; 87 (9): 717–719 [PMC free article] [PubMed] [Google Scholar]
  • 16. Light RW, Rogers JT, Cheng D‐S, Rodriguez RM, and Cardiovascular Surgery Associates, PC : Large pleural effusions occurring after coronary artery bypass grafting. Ann Intern Med 1999; 130: 891–896 [DOI] [PubMed] [Google Scholar]
  • 17. Vargas FS, Cukier A, Hueb W, Teixeira LR, Light RW: Relationship between pleural effusion and pericardial involvement after myocardial revascularization. Chest 1994; 105 (6): 1748–1752 [DOI] [PubMed] [Google Scholar]
  • 18. Kahn SR: The clinical diagnosis of deep vein thrombosis. Arch Intern Med 1998; 158: 2315–2323 [DOI] [PubMed] [Google Scholar]
  • 19. Kerstein MD, McSwain NE Jr, O'Connell RC, Webb WR, Brennan LA: Obesity: Is it really a risk factor in thrombophlebitis? South Med J 1987; 80 (10): 1236–1238 [PubMed] [Google Scholar]
  • 20. Hanson EC, Levine FH: Hyperlipoproteinemia as a significant risk factor for pulmonary embolism in patients undergoing coronary artery bypass grafting. Ann Thorac Surg 1982; 33: 593–598 [DOI] [PubMed] [Google Scholar]
  • 21. Heatley RV, Morgan A, Hughes LE, Okwonga W: Preoperative or postoperative deep‐vein thrombosis? Lancet 1976; 1: 437–439 [DOI] [PubMed] [Google Scholar]
  • 22. Sigel B, Ipsen J, Felix WR: The epidemiology of lower extremity deep vein thrombosis in surgical patients. Ann Surg 1974; 179: 278–290 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Aburahma A, Malik F, Boland J: Heparin‐induced thrombocytopenia with thrombotic complications. West Virginia Med J 1992; 88: 95–100 [PubMed] [Google Scholar]
  • 24. Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Wolf M, Meyer D: Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin‐induced thrombocytopenia. Thromb Haemost 1992; 68: 95–96 [PubMed] [Google Scholar]
  • 25. Visentin GP, Ford SE, Scott JP, Aster RH: Antibodies from patients with heparin‐induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994; 93: 81–88 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Kakkasseril JS, Cranley JJ, Panke T, Grannan K. Heparin‐induced thrombocytopenia : A prospective study of 142 patients. J Vase Surg 1985; 2: 382–384 [PubMed] [Google Scholar]
  • 27. Warkentin T, Levine M, Hirsh J, Horsewood P, Roberts R, Tech M, Gent M, Kelton J: Heparin‐induced thrombocytopenia in patients treated with low‐molecular‐weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330–1335 [DOI] [PubMed] [Google Scholar]
  • 28. Bauer TL, Arepally G, Konkle BA, Mestichelli B, Shapiro SS, Cines DB, Poncz M, McNulty S, Amiral J, Hauck WW, Edie RN, Mannion JD: Prevalence of heparin‐associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass. Circulation 1997; 95: 1242–1246 [DOI] [PubMed] [Google Scholar]
  • 29. Chong B: Heparin‐induced thrombocytopenia. Br J Haematol 1995; 89: 431–439 [DOI] [PubMed] [Google Scholar]
  • 30. Greinacher A, Amiral J, Dummel V, Vissac A, Kiefel V, Mueller‐Eckhardt C: Laboratory diagnosis of heparin‐induced thrombocytopenia and comparison of platelet aggregation test, heparin‐induced platelet activation test, and platelet factor 4/heaprin enzyme‐linked immunosorbent assay. Transfusion 1994; 34 (5): 381–385 [DOI] [PubMed] [Google Scholar]
  • 31. Greinacher A, Volpel H, Janssens U, Hach‐Wunderle V, Kemkes‐Matthes B, Eichler P, Mueller‐Velten H, Potzsch B, for the HIT Investigators Group: Recombinant hirudin (Lepirudin) provides safe and effective anticoagulation in patients with heparin‐induced thrombocytopenia. A prospective study. Circulation 1999; 99: 73–80 [DOI] [PubMed] [Google Scholar]
  • 32. Collins R, Scrimgeour A, Yusuf S, Peto R: Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 1988; 318: 1162–1173 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES